Maharashtra: Government-Run Blood Banks Slapped Rs 12.72 Lakh In Fines For Neglecting Daily Stock Updates, Reveals RTI Inquiry

Mumbai: The State Blood Transfusion Council imposed a fine of over Rs 12,72,000 on 93 government-run blood banks between December 2022 to April 2023 for not updating the daily blood stock at MahaSBTC and e-raktkosh portal.

The data was revealed through a Right To Information (RTI) filed by activist Chetan Kothari seeking data regarding penalties imposed on blood banks in the last five months. As per the RTI, RN Cooper blood banks tops the list of penalties in terms of violation. Out of a total 121 days, the blood bank has uploaded its blood stock on e-raktkosh only for 25 days.

“The daily stock on e-raktkosh has not been updated 11 times in December 2022, followed by 22 times in January 2023, six times in February, 27 times in March and 30 days in April. All these clearly show that blood banks have not taken GR seriously,” said Kothari.

The public health department had released a government resolution (GR) on December 2 stating that if banks are charging processing fee in excess of the amount stipulated by the National Blood Transfusion Council (NBTC), a penalty of five times the extra processing fee will be levied on the bank.

A senior blood transfusion officer said that often the families of the patients are least aware of the availability of the blood at blood banks. In view of this, the government created the e-blood bank website on which blood banks of all the states have to upload information about their stock. “The basic objective is that whenever a patient needs blood and there is no blood in the blood bank of the hospital, then they can go to thee-blood bank and search in which blood bank the blood is available,” he said.

 

Related Posts

  • Pharma
  • June 22, 2024
  • 92 views
Sun Pharma Inks Non-Exclusive License Agreement With Takeda To Introduce Vonoprazan Tablets In India

New Delhi: Sun Pharmaceutical Industries on Friday said it has inked a licensing pact with Takeda Pharmaceutical Company to commercialise a novel gastrointestinal drug in India. The company has entered…

  • Pharma
  • June 22, 2024
  • 104 views
Look-Alike, Sounding Similar Drugs Likely To Face Strict Action

NEW DELHI: Have you ever got confused by similar looking or same sounding medicines? Here is some good news. Drug manufacturers may face strict action by the drug regulatory authority for…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma Inks Non-Exclusive License Agreement With Takeda To Introduce Vonoprazan Tablets In India

Sun Pharma Inks Non-Exclusive License Agreement With Takeda To Introduce Vonoprazan Tablets In India

Look-Alike, Sounding Similar Drugs Likely To Face Strict Action

Look-Alike, Sounding Similar Drugs Likely To Face Strict Action

Centre Forms 5-Member Panel To Examine Manufacturing Of Nutraceuticals Within Drug Production Facility

Centre Forms 5-Member Panel To Examine Manufacturing Of Nutraceuticals Within Drug Production Facility

Indian Pharmacopoeia Commission Flags ADR Linked To Meropenem

Indian Pharmacopoeia Commission Flags ADR Linked To Meropenem

Plan To Regulate Nutraceutical Industry Underway

Plan To Regulate Nutraceutical Industry Underway

Ayush And Herbal Products Exports Grow Over 20% In April

Ayush And Herbal Products Exports Grow Over 20% In April